UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January ~~August 12~~20, ~~2014~~2015

NEUROMAMA, LTD.

(Exact name of registrant as specified in charter)


Nevada	333-180750	98-0706304
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

Blvd. Benito Juarez Km 25.500, Quinta Del Mar, Int. Suite 28

Playas de Rosarito B.C, Mexico

(Address of principal executive offices)

c.p. 22710

(Zip Code)

+52 (664) 290-5048

Registrant’s telephone number

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

Item 54.~~02.~~01 ~~Departure~~Changes ofin ~~Directors~~Registrant’s orCertifying ~~Certain Officers; Election of Directors; Appointment of Certain Officers~~Accountant.

On ~~August~~or 12about January 20, ~~2014~~2015, the Board of Directors of Neuromama, Ltd. (the “Company”) ~~received~~approved ~~resignation~~the ~~notices~~engagement ~~from~~of ~~Alexander~~MaloneBailey, ~~Vikoulov~~LLP (“MaloneBailey”) as ~~Chief~~its ~~Financial~~principal ~~Officer~~accountant ~~and~~to ~~Director~~audit of the Company’s financial statements as successor to Silberstein Ungar, PLLC CPAs. ~~Mr.~~During ~~Vikoulov~~the noCompany's ~~longer~~two ~~holds~~most ~~any~~recent ~~positions~~fiscal years or subsequent interim period, the Company has not consulted with the entity of MaloneBailey regarding the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, nor did the entity of MaloneBailey provide advice to the Company, either written or oral, that was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue.

~~Mr.~~Further, ~~Vikoulov’~~during the Company's ~~resignations~~two ~~were~~most ~~not~~recent ~~due~~fiscal toyears ~~any~~or ~~disagreement~~subsequent ~~with~~interim period, the Company has not consulted the entity of MaloneBailey on any matter ~~relating~~that towas ~~its~~the ~~operations,~~subject ~~policies~~of a disagreement or ~~practices~~a reportable event.

On August 12, 2014, the Company, and a majority of its shareholders by written consent, appointed Karapet Gevorgya, its current Treasurer and Secretary as its new Chief Financial Officer and as Director.

Mr. Gevorgyan studied Computer Aided Manufacturing in Cybernetics at the Yerevan Polytechnic Institute. From 2005 to present, Mr. Gevorgyan has worked at SNG/USA Event Production, a private company.

Mr. Gevorgyan will serve as our officer until his duly elected successor is appointed or he resigns. There are no arrangements or understandings between Mr. Gevorgyan and any other person pursuant to which he was selected as an officer. There are no family relationship between Mr. Gevorgyan and any of our officers or directors. Mr. Gevorgyan has not held any other directorships in a company with a class of securities registered pursuant to section 12 of the Exchange Act or subject to the requirements of section 15(d) of such Act or any company registered as an investment company under the Investment Company Act of 1940.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NEUROMAMA, LTD.
Date: September 4, 2014	By:	/s/ Igor Weselovsky
Date: January 30, 2015	By:	/s/ Igor Weselovsky
		Igor Weselovsky, President, Chief Executive Officer & Director

Filing Compare · NEUROMAMA, LTD.